Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for BioCorRx (BICX) over the last 9 years, with Q3 2025 value amounting to $69803.0.

  • BioCorRx's Non-Current Debt changed N/A to $69803.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $69803.0, marking a year-over-year change of. This contributed to the annual value of $71029.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, BioCorRx's Non-Current Debt is $69803.0.
  • In the past 5 years, BioCorRx's Non-Current Debt ranged from a high of $74300.0 in Q4 2021 and a low of $69803.0 during Q3 2025
  • Over the past 4 years, BioCorRx's median Non-Current Debt value was $72439.5 (recorded in 2022), while the average stood at $72245.5.
  • Over the last 5 years, BioCorRx's Non-Current Debt had its largest YoY gain of 60.57% in 2022, and its largest YoY loss of 60.57% in 2022.
  • Quarter analysis of 4 years shows BioCorRx's Non-Current Debt stood at $74300.0 in 2021, then dropped by 0.61% to $73850.0 in 2022, then fell by 3.82% to $71029.0 in 2024, then dropped by 1.73% to $69803.0 in 2025.
  • Its Non-Current Debt stands at $69803.0 for Q3 2025, versus $71029.0 for Q4 2024 and $73850.0 for Q4 2022.